E R Dabbs
Overview
Explore the profile of E R Dabbs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chengalroyen M, Dabbs E
World J Microbiol Biotechnol
. 2012 Nov;
29(4):625-33.
PMID: 23188379
Investigation into the biodegradative capability of several actinomycetes led to the discovery of many strains possessing an ability to decolorize a variety of azo and triphenylmethane dyes. Of particular interest...
2.
Chengalroyen M, Dabbs E
World J Microbiol Biotechnol
. 2012 Oct;
29(3):389-99.
PMID: 23108664
The removal of dyes in wastewater treatment plants still involves physical or chemical processes. Yet numerous studies currently exist on degradation based on the use of microbes-which is a well-studied...
3.
Morisaki N, Hashimoto Y, Furihata K, Imai T, Watanabe K, Mikami Y, et al.
J Antibiot (Tokyo)
. 2000 May;
53(3):269-75.
PMID: 10819298
23-(O-ADP-Ribosyl)rifampicin [RIP-TAs (3, Na+ form), RIP-TAf (4, H+ form)] was obtained as an intermediate in the conversion process of rifampicin (1) to RIP-Mb (2) that is mediated by cell homogenates...
4.
Imai T, Watanabe K, Mikami Y, Yazawa K, Ando A, Nagata Y, et al.
Microb Drug Resist
. 2000 Jan;
5(4):259-64.
PMID: 10647083
Mycobacterium smegmatis DSM 43756 inactivates rifampin by ribosylation. To study this process of rifampicin, all possible inactivated forms of the antibiotic were extracted and purified. Structural studies showed the presence...
5.
Dabbs E, Quan S
FEMS Microbiol Lett
. 1999 Dec;
182(1):105-9.
PMID: 10612740
Rifampicin is a principal drug used to combat infections by mycobacteria and related organisms. Most strains of Mycobacterium are able to inactivate this antibiotic by ribosylation via an ADP-ribosylated intermediate....
6.
Dabbs E
Antonie Van Leeuwenhoek
. 1999 Mar;
74(1-3):155-67.
PMID: 10068797
Generalised and specialised transduction systems were developed for Rhodococcus by means of bacteriophage Q4. The latter was used in conjunction with DNA from an unstable genetic element of R. rhodochrous...
7.
Quan S, Imai T, Mikami Y, Yazawa K, Dabbs E, Morisaki N, et al.
Antimicrob Agents Chemother
. 1998 Dec;
43(1):181-4.
PMID: 9869590
Mycobacterium smegmatis DSM43756 inactivates rifampin, and the inactivated antibiotic product recovered from culture medium was ribosylated on the 23-OH group. To study this process, the gene responsible for the inactivation...
8.
Quan S, Venter H, Dabbs E
Antimicrob Agents Chemother
. 1997 Nov;
41(11):2456-60.
PMID: 9371349
Mycobacterium smegmatis inactivates rifampin by ribosylating this antibiotic. The gene responsible for this ability was cloned and was shown to confer low-level resistance to this antibiotic (MIC increase, about 12-fold)...
9.
Andersen S, Quan S, Gowan B, Dabbs E
Antimicrob Agents Chemother
. 1997 Jan;
41(1):218-21.
PMID: 8980786
A DNA clone from Rhodococcus equi conferring low-level rifampin resistance through the ability to inactivate this antibiotic via its decomposition was identified. The iri (inactivation of rifampin) gene consisted of...
10.
Kesseler M, Dabbs E, Averhoff B, Gottschalk G
Microbiology (Reading)
. 1996 Nov;
142 ( Pt 11):3241-51.
PMID: 8969521
The enzymes responsible for the degradation of isopropylbenzene (IPB) and co-oxidation of trichloroethene (TCE) by Rhodococcus erythropolis BD2 are encoded by the linear plasmid pBD2. Fragments containing IPB catabolic genes...